Outlook Therapeutics, Inc. (OTLK)
0.5898
+0.19
(+47.38%)
USD |
NASDAQ |
May 27, 16:00
0.58
-0.01
(-1.66%)
After-Hours: 16:47
Outlook Therapeutics Free Cash Flow : -51.25M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| XOMA Royalty Corp. | -14.09M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Amgen, Inc. | 8.597B |
| Savara, Inc. | -106.97M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.828M |
| Cash from Financing (Quarterly) | 6.899M |
| Free Cash Flow Per Share (Quarterly) | -0.0957 |
| Free Cash Flow to Equity (Quarterly) | 1.877M |
| Free Cash Flow to Firm (Quarterly) | -7.828M |
| Free Cash Flow Yield | -165.6% |